Investor Presentaiton slide image

Investor Presentaiton

31st January 2024 Branded Generics Sales Continues to Grow 5% India (Rs. cr.) 308 294 227 28% Asia (Rs. Cr.) 7% Africa (Rs. Cr.) 13% Total (Rs. Cr.) Q3 Consolidated 755 292 155 666 145 ■Q3 FY23 Q3 FY24 Q3 FY23 ■ Q3 FY24 ■ Q3 FY23 ■ Q3 FY24 Q3 FY23 Q3 FY24 28% 27% 14% of Total Revenue of Total Revenue of Total Revenue 69% of Total Revenue ajanta
View entire presentation